Katalóg evidencie publikačnej činnosti PU

ID záznamu:	163724
Kategória:	ADC
Autor:	Kapelios Chris J. (1%)
Autor:	Lainscak Matja (0%)
Autor:	Savarese Gianluigi (0%)
Autor:	Laroche Cecile (0%)
Autor:	Seferovic Petar (0%)
Autor:	Murín Ján (0%)
Autor:	Goncalvesová Eva (0%)
Autor:	Kmec Ján (0%)
Názov:	Sacubitril/valsartan eligibility and outcomes in the ESC-EORP-HFA Heart Failure Long-Term Registry: bridging between European Medicines Agency/Food and Drug Administration label, the PARADIGM-HF trial, ESC guidelines, and real world [print]
Zdroj:	European Journal of Heart Failure [print, elektronický dokument] : journal of the Working Group on Heart Failure of the European Society of Cardiology
Lokácia:	Roč. 21, č. 11. - Chichester, WestSussex, (2019), s. 1383-1397
ISSN:	1388-9842. - ISSN 1879-0844
URL:	https://onlinelibrary.wiley.com/doi/epdf/10.1002/ejhf.1532
Ohlas:	[1] 2019. AMBROSY, Andrew P., FUDIM, Marat, CHIONCEL, Ovidiu. Should providers prescribe sacubitril/valsartan based on trial eligibility, approval indication, or guideline recommendations?. In European Journal of Heart Failure : print, elektronický dokument, ISSN 1388-9842; 1879-0844. Chichester, WestSussex, 2019, Roč. 21, č. 11, 1398-1401.
Ohlas:	[1] 2020. NORDBERG BACKELIN, Charlotte, FU, Michael, LJUNGMAN, Charlotta. Early experience of Sacubitril–Valsartan in heart failure with reduced ejection fraction in real-world clinical setting. In ESC heart failure : elektronický dokument, ISSN 2055-5822. [Oxford], 2020, Roč. 7, č. 3, 1049-1055.
Ohlas:	[1] 2020. MAZZETTI, Simone, SCIFO, Chiara, ABETE, Raffaele et al. Short-term echocardiographic evaluation by global longitudinal strain in patients with heart failure treated with sacubitril/valsartan. In ESC heart failure : elektronický dokument, ISSN 2055-5822. [Oxford], 2020, Roč. 7, č. 3, s. 964-972.
Ohlas:	[1] 2020. LEMONNIER, J., RAJKUMAR, A., GAUTIER, Mathieu et al. Sacubitril/Valsartan: Follow-up of a heart failure cohort of patients in real life. In Pharmacien Hospitalier et Clinicien : print, ISSN 2211-1042. 2020, Roč. 55, č. 1, s. 42-47.
Ohlas:	[1] 2020. CLELAND, John G.F., LYON, Alexander R., MCDONAGH, Theresa A. et al. The year in cardiology: Heart failure. In European Heart Journal : print, elektronický dokument, ISSN 0195-668X; 1522-9645. Barcelona, 2020, Roč. 41, č. 12, s. 1232-1248.
Ohlas:	[1] 2020. CHEN, Peng yuan, LIU, Yuan hui, DUAN, Chong yang et al. Association of in-hospital intensive statins dosage and death in arteriosclerotic cardiovascular disease with percutaneous coronary intervention: insights of multicentre cohort from China. In European journal of clinical pharmacology : print, elektronický dokument, ISSN 0031-6970; 1432-1041. Heidelberg, 2020, Roč. 76, č. 12, 1755-1763.
Ohlas:	[1] 2020. CHEN, Xiaojing, SCHAUFELBERGER, Maria, FU, Michael. The eligible population of the PARADIGM-HF trial in a real-world outpatient clinic and its cardiovascular risk between 2005 and 2016. In Journal of cardiovascular medicine : print, elektronický dokument, ISSN 1558-2027; 1558-2035. Hagerstown, 2020, Roč. 21, č. 1, 6-12.
Ohlas:	[1] 2020. DI LORENZO, Anna, IANNUZZO, Gabriella, PARLATO, Alessandro et al. Clinical Evidence for Q10 Coenzyme Supplementation in Heart Failure: From Energetics to Functional Improvement. In Journal of clinical medicine : elektronický dokument, ISSN 2077-0383. Bazilej, 2020, Roč. 9, č. 5. WOS CC ; CCC ; SCO.
Ohlas:	[1] 2020. CHALIKIAS, George, TZIAKAS, Dimitrios. Angiotensin Receptor Neprilysin Inhibitors—2019 Update. In Cardiovascular drugs and therapy : print, elektronický dokument, ISSN 0920-3206; 1573-7241. Norwell , 2020, Roč. 34, č. 5, 707-722.
Ohlas:	[1] 2021. GATTI, Milo, ANTONAZZO, Ippazio Cosimo, DIEMBERGER, Igor et al. Adverse events with sacubitril/valsartan in the real world: emerging signals to target preventive strategies from the FDA adverse event reporting system. In European Journal of Preventive Cardiology : print, elektronický dokument, ISSN 2047-4873; 2047-4881. Londýn, 2021, Roč. 28, č. 9, s. 983-989.
Ohlas:	[1] 2020. DE LA ESPRIELLA, Rafael, BAYÉS-GENÍS, Antoni, NUNEZ, Julio. Efficacy and safety of combined neprilysin and RAS inhibition in heart failure: Let's leave the doubts behind. In International Journal of Cardiology : print, elektronický dokument, ISSN 0167-5273; 1874-1754. Amsterdam, 2020, č. 300, s. 198-200.
Ohlas:	[1] 2021. FONG, Man Cai, CHANG, Hung Yu, WANG, Chun Chieh et al. The characteristics and outcomes of patients with heart failure and reduced ejection fraction: The eligibility of novel heart failure medications. In Acta Cardiologica Sinica : print, ISSN 1011-6842. Taipei, 2021, Roč. 37, č. 4, 394-403.
Ohlas:	[1] 2021. BORIANI, Giuseppe, DE PONTI, Roberto, GUERRA, Federico et al. Sinergy between drugs and devices in the fight against sudden cardiac death and heart failure. In European Journal of Preventive Cardiology : print, elektronický dokument, ISSN 2047-4873; 2047-4881. Londýn, 2021, Roč. 28, č. 1, 110-123.
Oblasť výskumu:	180